Showing posts with label Lucentis. Show all posts
Showing posts with label Lucentis. Show all posts

Friday, June 18, 2010

Medicare Could Save $500 Million By Switching Drugs For AMD Treatment






Wall Street Journal reports that Medicare could achieve an annual savings of at least $500 million by switching from Lucentis (ranibizumab) to Avastin (bevacizumab) for the treatment of wet age-related macular degeneration (AMD).

After examining data on some 200,000 patients on Medicare, researchers found that expenditures for Avastin averaged about $42 per dose per eye, compared to $1,593 for a dose of Lucentis.

These study results have not yet been submitted to a medical journal for peer review, a fact that troubles Sen. Herb Kohl (D-WI), who chairs the Senate Committee on Aging. Kohl stated, "It is baffling that CMS would delay the release of this data when there are hundreds of millions of taxpayer dollars at stake.
Enhanced by Zemanta

Wednesday, October 28, 2009

The Wall Street Journal "Health Blog" reported that the Centers for Medicare & Medicaid Services (CMS) appears late yesterday to have changed its mind about reimbursement for small amounts of Avastin [bevacizumab], which physicians use to treat patients with age-related macular degeneration (AMD).


Avastin, which is similar to Lucentis [ranibizumab], is used off-label to manage AMD, but unlike Lucentis, which costs approximately $2,000 per injection, Avastin costs only about $30 per injection, making it considerably cheaper. Late yesterday, however, CMS announced without explanation that as of Jan. 1, it will reverse its Oct. 1 decision to reimburse Avastin at approximately $7 per dose, and will return to its previous higher reimbursement for the drug.


MedPage Today explained that even after CMS lowered its reimbursement for Avastin on Oct. 1, "reimbursement for Lucentis...remained unchanged at a whopping $2,039," thereby creating "a disincentive for using a drug that has been estimated to save Medicare $1.5 billion each year in treating macular degeneration alone.
Reblog this post [with Zemanta]

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review